Alantos Pharmaceuticals
Cambridge
About Alantos Pharmaceuticals
Alantos Pharmaceuticals is a chemistry-driven biopharmaceutical company. It engages in the discovery and development of small molecule drugs for osteoarthritis, inflammation, and type II diabetes. Their products include Dipeptidyl and Peptidase IV inhibitor. The company offers various tissue remodeling pathways for rheumatoid arthritis, liver fibrosis, cardiovascular, chronic wound healing, and cancer. Alantos Pharmaceuticals was founded in 2002 and is based in Cambridge, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Total funding: $47.7M
- Funding stage: M&A
- Last round: Series B (Mar 2005)
- Website: alantos.com
- Phone: 408-215-2800
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/alantos-pharmaceuticals-3086590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.